19,631 research outputs found
Inverse Projection Representation and Category Contribution Rate for Robust Tumor Recognition
Sparse representation based classification (SRC) methods have achieved
remarkable results. SRC, however, still suffer from requiring enough training
samples, insufficient use of test samples and instability of representation. In
this paper, a stable inverse projection representation based classification
(IPRC) is presented to tackle these problems by effectively using test samples.
An IPR is firstly proposed and its feasibility and stability are analyzed. A
classification criterion named category contribution rate is constructed to
match the IPR and complete classification. Moreover, a statistical measure is
introduced to quantify the stability of representation-based classification
methods. Based on the IPRC technique, a robust tumor recognition framework is
presented by interpreting microarray gene expression data, where a two-stage
hybrid gene selection method is introduced to select informative genes.
Finally, the functional analysis of candidate's pathogenicity-related genes is
given. Extensive experiments on six public tumor microarray gene expression
datasets demonstrate the proposed technique is competitive with
state-of-the-art methods.Comment: 14 pages, 19 figures, 10 table
Identification of disease-causing genes using microarray data mining and gene ontology
Background: One of the best and most accurate methods for identifying disease-causing genes is monitoring gene expression values in different samples using microarray technology. One of the shortcomings of microarray data is that they provide a small quantity of samples with respect to the number of genes. This problem reduces the classification accuracy of the methods, so gene selection is essential to improve the predictive accuracy and to identify potential marker genes for a disease. Among numerous existing methods for gene selection, support vector machine-based recursive feature elimination (SVMRFE) has become one of the leading methods, but its performance can be reduced because of the small sample size, noisy data and the fact that the method does not remove redundant genes.
Methods: We propose a novel framework for gene selection which uses the advantageous features of conventional methods and addresses their weaknesses. In fact, we have combined the Fisher method and SVMRFE to utilize the advantages of a filtering method as well as an embedded method. Furthermore, we have added a redundancy reduction stage to address the weakness of the Fisher method and SVMRFE. In addition to gene expression values, the proposed method uses Gene Ontology which is a reliable source of information on genes. The use of Gene Ontology can compensate, in part, for the limitations of microarrays, such as having a small number of samples and erroneous measurement results.
Results: The proposed method has been applied to colon, Diffuse Large B-Cell Lymphoma (DLBCL) and prostate cancer datasets. The empirical results show that our method has improved classification performance in terms of accuracy, sensitivity and specificity. In addition, the study of the molecular function of selected genes strengthened the hypothesis that these genes are involved in the process of cancer growth.
Conclusions: The proposed method addresses the weakness of conventional methods by adding a redundancy reduction stage and utilizing Gene Ontology information. It predicts marker genes for colon, DLBCL and prostate cancer with a high accuracy. The predictions made in this study can serve as a list of candidates for subsequent wet-lab verification and might help in the search for a cure for cancers
Algorithms Implemented for Cancer Gene Searching and Classifications
Understanding the gene expression is an important factor to cancer diagnosis. One target of this understanding is implementing cancer gene search and classification methods. However, cancer gene search and classification is a challenge in that there is no an obvious exact algorithm that can be implemented individually for various cancer cells. In this paper a research is con-ducted through the most common top ranked algorithms implemented for cancer gene search and classification, and how they are implemented to reach a better performance. The paper will distinguish algorithms implemented for Bio image analysis for cancer cells and algorithms implemented based on DNA array data. The main purpose of this paper is to explore a road map towards presenting the most current algorithms implemented for cancer gene search and classification
Machine Learning and Integrative Analysis of Biomedical Big Data.
Recent developments in high-throughput technologies have accelerated the accumulation of massive amounts of omics data from multiple sources: genome, epigenome, transcriptome, proteome, metabolome, etc. Traditionally, data from each source (e.g., genome) is analyzed in isolation using statistical and machine learning (ML) methods. Integrative analysis of multi-omics and clinical data is key to new biomedical discoveries and advancements in precision medicine. However, data integration poses new computational challenges as well as exacerbates the ones associated with single-omics studies. Specialized computational approaches are required to effectively and efficiently perform integrative analysis of biomedical data acquired from diverse modalities. In this review, we discuss state-of-the-art ML-based approaches for tackling five specific computational challenges associated with integrative analysis: curse of dimensionality, data heterogeneity, missing data, class imbalance and scalability issues
Artificial Neural Network Inference (ANNI): A Study on Gene-Gene Interaction for Biomarkers in Childhood Sarcomas
Objective: To model the potential interaction between previously identified biomarkers in children sarcomas using artificial neural network inference (ANNI).
Method: To concisely demonstrate the biological interactions between correlated genes in an interaction network map, only 2 types of sarcomas in the children small round blue cell tumors (SRBCTs) dataset are discussed in this paper. A backpropagation neural network was used to model the potential interaction between genes. The prediction weights and signal directions were used to model the strengths of the interaction signals and the direction of the interaction link between genes. The ANN model was validated using Monte Carlo cross-validation to minimize the risk of over-fitting and to optimize generalization ability of the model.
Results: Strong connection links on certain genes (TNNT1 and FNDC5 in rhabdomyosarcoma (RMS); FCGRT and OLFM1 in Ewing’s sarcoma (EWS)) suggested their potency as central hubs in the interconnection of genes with different functionalities. The results showed that the RMS patients in this dataset are likely to be congenital and at low risk of cardiomyopathy development. The EWS patients are likely to be complicated by EWS-FLI fusion and deficiency in various signaling pathways, including Wnt, Fas/Rho and intracellular oxygen.
Conclusions: The ANN network inference approach and the examination of identified genes in the published literature within the context of the disease highlights the substantial influence of certain genes in sarcomas
Hybrid Approach of Relation Network and Localized Graph Convolutional Filtering for Breast Cancer Subtype Classification
Network biology has been successfully used to help reveal complex mechanisms
of disease, especially cancer. On the other hand, network biology requires
in-depth knowledge to construct disease-specific networks, but our current
knowledge is very limited even with the recent advances in human cancer
biology. Deep learning has shown a great potential to address the difficult
situation like this. However, deep learning technologies conventionally use
grid-like structured data, thus application of deep learning technologies to
the classification of human disease subtypes is yet to be explored. Recently,
graph based deep learning techniques have emerged, which becomes an opportunity
to leverage analyses in network biology. In this paper, we proposed a hybrid
model, which integrates two key components 1) graph convolution neural network
(graph CNN) and 2) relation network (RN). We utilize graph CNN as a component
to learn expression patterns of cooperative gene community, and RN as a
component to learn associations between learned patterns. The proposed model is
applied to the PAM50 breast cancer subtype classification task, the standard
breast cancer subtype classification of clinical utility. In experiments of
both subtype classification and patient survival analysis, our proposed method
achieved significantly better performances than existing methods. We believe
that this work is an important starting point to realize the upcoming
personalized medicine.Comment: 8 pages, To be published in proceeding of IJCAI 201
- …